Why Novavax Inc (NVAX) Stock Is Rising
As of 2026-10-10, Novavax Inc (NVAX) has a next-year EPS growth estimate of 104.65%. Featured in our EPS revision report on 2026-10-10.
Why NVAX Stock Is Rising
- +EPS Estimate Upgraded: Analysts raised Novavax Inc's next-year EPS growth estimate from 77.26% to 97.29% on 2026-10-07.
- →Estimate Trending Higher: Since detection, the estimate has moved up a net +7.36 pp to 104.65% across 1 upward revision.
- !Largest Single-Day Revision: +7.36 pp on 2026-10-09 (97.29% → 104.65%).
- ·Current-Year Growth: Projected at -126.09%, supporting the forward estimate revision.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 104.65%
- EPS growth this year
- -126.09%
- EPS next quarter (est)
- -$0.22
- Last price
- $12.75
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-10-10 | 104.65% | -126.09% | -$0.22 | $12.75 |
| 2026-10-09 | 104.65% | -126.09% | -$0.22 | $12.75 |
| 2026-10-08 | 97.29% | -128.75% | -$0.24 | $11.01 |
| 2026-10-07 | 97.29% | -128.75% | -$0.24 | $11.22 |
| 2026-10-06 | 77.26% | -128.75% | -$0.24 | $11.32 |
| 2026-10-05 | 79.60% | -128.25% | -$0.23 | $12.56 |
| 2026-10-04 | 79.60% | -128.25% | -$0.23 | $10.46 |
| 2026-10-03 | 79.60% | -128.25% | -$0.23 | $10.46 |
| 2026-10-02 | 79.60% | -128.25% | -$0.23 | $10.46 |
| 2026-10-01 | 79.60% | -128.25% | -$0.23 | $10.60 |
| 2026-09-30 | 79.60% | -128.25% | -$0.23 | $10.81 |
| 2026-09-29 | 79.60% | -128.25% | -$0.23 | $10.82 |
| 2026-09-28 | 79.60% | -128.25% | -$0.23 | $10.80 |
| 2026-09-27 | 79.60% | -128.25% | -$0.23 | $10.63 |
| 2026-09-25 | 79.60% | -128.25% | -$0.23 | $10.63 |
| 2026-09-24 | 79.60% | -128.25% | -$0.23 | $10.60 |
| 2026-09-23 | 79.60% | -128.25% | -$0.23 | $10.55 |
| 2026-09-22 | 79.60% | -128.25% | -$0.23 | $10.83 |
| 2026-09-21 | 79.60% | -128.25% | -$0.23 | $10.41 |
| 2026-09-20 | 79.60% | -128.25% | -$0.23 | $10.11 |
| 2026-09-18 | 79.60% | -128.25% | -$0.23 | $10.11 |
| 2026-09-17 | 79.60% | -128.25% | -$0.23 | $10.00 |
| 2026-09-16 | 79.60% | -128.25% | -$0.23 | $9.35 |
| 2026-09-15 | 79.60% | -128.25% | -$0.23 | $9.23 |
| 2026-09-14 | 79.60% | -128.25% | -$0.23 | $9.59 |
| 2026-09-13 | 79.60% | -128.25% | -$0.23 | $9.42 |
| 2026-09-11 | 79.60% | -128.25% | -$0.23 | $9.42 |
| 2026-09-10 | 79.60% | -128.25% | -$0.23 | $9.30 |
| 2026-09-09 | 79.60% | -128.25% | -$0.23 | $9.85 |
| 2026-09-08 | 79.60% | -128.25% | -$0.23 | $10.19 |
Reports Featuring NVAX
Recent News
- Novavax and Moderna Shares Fall as Citi Assesses Vaccine Sector VolatilityInvestorsHub
- Pandemic Panic Is Back on Wall Street. What to Know About the Russian Plague Scare.Barrons.com
- Novavax, Moderna stocks fall after WHO calls plague risk 'low'Yahoo Finance
- Novavax Sinks 12% as WHO Calls Plague Risk Very LowTIKR
- Activist investor revives campaign to overhaul Novavax boardBioPharma Dive
- Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & DevelopmentPR Newswire
Screen Performance
Aggregate stats across all 2077 tickers our top-EPS-revision screen has flagged over the past 192 days.
- Median return since detection
- -0.9%
- % of tickers in the green
- 47%
- Median return on winners
- +23.2%
- Large revisions captured
- 1848
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
Why did Novavax Inc (NVAX) stock go up recently?▾
Novavax Inc (NVAX) stock has risen following an analyst upgrade of its next-year EPS growth estimate from 77.26% to 97.29% on 2026-10-07. Since detection, the estimate has moved up a net +7.36 pp to 104.65%. EPS estimate upgrades are among the strongest leading indicators of stock outperformance.
What is Novavax Inc's next-year EPS growth estimate?▾
As of 2026-10-10, Novavax Inc (NVAX) has a next-year EPS growth estimate of 104.65%, based on analyst consensus.
When was the latest EPS estimate revision for NVAX?▾
The most recent revision occurred on 2026-10-09, when analysts adjusted the next-year EPS growth estimate from 97.29% to 104.65%.
What sector and industry does Novavax Inc belong to?▾
Novavax Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. NVAX appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Novavax Inc (NVAX) appears here because it was detected by our daily top-EPS-revision-performer screen.